Survivin protein was positive in 22 out of 24 high-grade DCIS cases (78.6%), whereas in the group of 13 low-grade DCIS cases, survivin was positive in 6 of them (21.4%). Here, BIRC5 is linked to ductal breast carcinoma in situ.